ArriVent BioPharma Inc

AVBPNASDAQ · USD
29.54USD0.00 (+0.82%)
229

ArriVent BioPharma Inc (AVBP) Covered Calls

As of September 28, 2026, AVBP has 16 covered call opportunities in the coming three months. Return ranges from 11.1 to 81.0% until expiration. Annualized return ranges from 50.9 to 1,322.7%. The nearest expiration is October 16, 2026. Maximum potential profit is $2,305.

Read more

Running AVBP covered calls helps you generate consistent income from ArriVent BioPharma Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on ArriVent BioPharma Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best AVBP covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if AVBP stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling AVBP covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given ArriVent BioPharma Inc covered call is worth writing.

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc.

The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

Income-focused investors, long-term AVBP holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling AVBP covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best ArriVent BioPharma Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile76.19% Elevated
  • Market cap (M$)1,457
  • 52 weeks high-17.56%
  • 52 weeks low73.76%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$44.91
    52.03% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-16
  • P/E—
  • Future P/E—
  • EPS (ttm)-3.68
  • EPS growth next 5 years23.74%

As of September 28, 2026

2026-10-162150.0075.750.104.902165.0076.101322.66-0.35+0.29724.80
2026-10-162145.0058.170.104.901665.0058.521017.20-0.35+0.31374.80
2026-10-162135.0023.020.154.90670.0023.55409.32-0.53+0.388094.75
2026-11-205640.0040.600.805.501235.0043.41282.94-2.81+0.3804.70
2027-01-1511250.0075.751.504.702305.0081.02264.04-5.27+0.33593.20
2027-01-1511245.0058.171.156.001770.0062.21202.75-4.04+0.372034.85
2026-10-162130.005.451.605.70315.0011.07192.44-5.62+0.525484.10
2026-11-205635.0023.021.706.50825.0029.00189.01-5.98+0.4604.80
2027-01-1511240.0040.601.856.501340.0047.10153.50-6.50+0.435514.65
2027-04-1620345.0058.172.006.501855.0065.20117.24-7.03+0.4184.50

As of September 28, 2026

Sell covered calls with the data behind you

Find the best AVBP covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial